(Q37119451)

English

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination

scientific article published on 25 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

David C. Montefiori

11

object named as

David C Montefiori

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Francine E McCutchan

12

object named as

Francine E McCutchan

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

13

object named as

Nelson L Michael

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Victoria R Polonis

1

object named as

Victoria R Polonis

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

author name string

Bruce K Brown

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Andrew Rosa Borges

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Susan Zolla-Pazner

4

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Dimiter S Dimitrov

5

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Mei-Yun Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Susan W Barnett

7

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Ruth M Ruprecht

8

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Gabriella Scarlatti

9

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Eva-Maria Fenyö

10

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

language of work or name

0 references

publication date

25 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

375

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

315-320

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Plunder and stowaways: incorporation of cellular proteins by enveloped viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

AIDS research. Did Merck's failed HIV vaccine cause harm?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Humoral immunity to HIV-1: neutralization and beyond.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Antibody-based HIV-1 vaccines: recent developments and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Role of neutralizing antibodies in protective immunity against HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Mechanisms contributing to the neutralization of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Identifying epitopes of HIV-1 that induce protective antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2008.02.007

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2008.02.007

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37119451&oldid=2126491193"